Who is sponsoring NCT06825195?

NCT06825195 is sponsored by Dilara Ekici Zincirci.

What drugs are being tested in NCT06825195?

Interventions in NCT06825195: isokinetic muscle strength measurement, Minimum pinch force measurement.

What condition does NCT06825195 study?

NCT06825195 studies Fibromyalgia, Force Measurement, Isokinetic, Muscle Strength.

Is NCT06825195 still recruiting?

NCT06825195 is currently completed. Last updated 26 June 2025.

Last reviewed 2025-06-26 · How we verify

NCT06825195

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Fingertip Precision Pinch Force in Fibromyalgia Patients

Completed Last updated 26 June 2025

What this trial tests

trial testing isokinetic muscle strength measurement in Fibromyalgia in 108 participants. Completed in 14 March 2025.

Timeline

11 November 2024

Primary endpoint
11 November 2024

14 March 2025

Quick facts

Lead sponsor	Dilara Ekici Zincirci
Status	Completed
Study type	OBSERVATIONAL
Enrollment	108
Start date	11 November 2024
Primary completion	11 November 2024
Estimated completion	14 March 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

isokinetic muscle strength measurement
Minimum pinch force measurement

Conditions studied

Fibromyalgia — all drugs for Fibromyalgia →
Force Measurement — all drugs for Force Measurement →
Isokinetic — all drugs for Isokinetic →
Muscle Strength — all drugs for Muscle Strength →

Sponsor

Dilara Ekici Zincirci

Who can join

Adults 18 to 70, female only, with Fibromyalgia or Force Measurement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the force used by fibromyalgia patients during a task compared to healthy volunteers and to evaluate its relationship with fatigue seen in these patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting

Other Dilara Ekici Zincirci trials

Trials by the same sponsor.

NCT06562218 — The Effectiveness of Cross-training on an Immobilised Forearm · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06825195 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dilara Ekici Zincirci
Last refreshed: 26 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06825195.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing